Clinical Trial: Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07640776) titled 'Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)' on June 05.

Brief Summary: This study will evaluate the safety and effectiveness of using Irreversible Electroporation (IRE) for the treatment of symptomatic benign prostatic hyperplasia (BPH).

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)

Intervention: DEVICE: Irreversible Electroporation

Treatment with the NanoKnife System for ablation of prostate tissue. The procedure will be perfor...